Application of a canine 238Pu biokinetics/dosimetry model to human bioassay data.
Associated with the use of 238Pu in thermoelectric power sources for space probes is the potential for human exposure, primarily by inhalation and most likely as 238PuO2. Several models have been developed for assessing the level of intake and predicting the resulting radiation dose following human exposure to 239Pu. However, there are indications that existing models do not adequately describe the disposition and dosimetry of 238Pu following human exposure. In this study, a canine model that accounts for these differences has been adapted for use with human excretion data. The model is based on existing knowledge about organ retention of plutonium. An analysis of the sensitivity of the model to changes in aerosol-associated properties indicated that predictions of urinary excretion are most sensitive to changes in particle solubility and diameter and in the ratio of fragment:particle surface area. Application of the model to urinary excretion data from seven workers exposed to a 238Pu ceramic aerosol gave estimated intakes of 390-8,200 Bq and associated initial pulmonary burdens of 80-1,700 Bq. The resulting 50-y dose commitments to critical organs per Bq of 238Pu intake were estimated to be 0.5 mSv for the thoracic region, 0.2 mSv for the liver, and 1 mSv for the bone surfaces.
Department of Nuclear Engineering Sciences, University of Florida, Gainesville 32611.
A W
AW
Hickman
W C
WC
Griffith
G S
GS
Roessler
R A
RA
Guilmette
D000818:Animals; D001345:Autoradiography; D003198:Computer Simulation; D004285:Dogs; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D008954:Models, Biological; D016273:Occupational Exposure; D011005:Plutonium / Q000032:analysis* / Q000493:pharmacokinetics*; D011834:Radiation Monitoring / Q000379:methods; D018788:Radioactive Hazard Release; D011859:Radiography; D018531:Spacecraft; D014018:Tissue Distribution
D011005:Plutonium